Mettler Toledo International Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.59% of US listed stocks.
MTD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,436.42 -- higher than 97.38% of US-listed equities with positive expected earnings growth.
In terms of volatility of its share price, MTD is more volatile than merely 2.49% of stocks we're observing.
Stocks that are quantitatively similar to MTD, based on their financial statements, market capitalization, and price volatility, are CLX, TSCO, POOL, JBHT, and PKI.
MTD's SEC filings can be seen here. And to visit Mettler Toledo International Inc's official web site, go to www.mt.com.
Mettler-Toledo International, Inc. (MTD) Company Bio
Mettler-Toledo International is a provider of weighing instruments for use in laboratory, industrial and food retailing applications. The Company is also a provider in analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes. As well, the company supplies inspection systems used in production and packaging for food, pharmaceutical and other industries. The company was founded in 1991 and is based in Columbus, Ohio.
MTD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Mettler Toledo International Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Mettler Toledo International Inc ranked in the 22th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 67.67%. In terms of the factors that were most noteworthy in this DCF analysis for MTD, they are:
The company's debt burden, as measured by earnings divided by interest payments, is 18.5; that's higher than 81.75% of US stocks in the Healthcare sector that have positive free cash flow.
The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than only 17.94% of the free cash flow producing stocks we're observing.
MTD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 45.61% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MTD, try BAX, DHR, VIVO, ELMD, and PBYI.
Mettler-Toledo International Inc. (MTD) today announced the webcast of its presentation at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020, at 1:00 p.m. Eastern Time. To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors. METTLER TOLEDO (MTD) is a leading global supplier of precision instruments and services.
Mettler-Toledo International Inc. (MTD) today announced the webcast of its presentation at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020, at 12:30 p.m Eastern Time. To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors. METTLER TOLEDO (MTD) is a leading global supplier of precision instruments and services.